Posted in

News

Short & Long Term effects of DBS discussed at World Parkinson Congress

Dr. Michael Okun presented “DBS Outcomes: What can you expect in the short term and the long term?” at the 2016 World Parkinson Congress. To watch: Click here to register Choose September 21st Click Dr. Okun’s talk in the list There are lots of other great talks on that page!

Remembering Muhammad Ali and his impact on Parkinson care and research

Muhammad Ali will be remembered for a great many things in and out of the boxing ring. In addition to those things, we at the UF Health Center for Movement Disorders and Neurorestoration were impressed with how he lived with Parkinson disease and did so in such a public way. One example would be his…

Updated Gainesville Support Group Information

Support Groups! We’ve updated the flyers for these local support groups. Young Onset Parkinson’s Parkinson’s Patients and their Caregivers Essential Tremor Fronto-Temporal Dementia Download the Gainesville Support Group Flyers

Dr. Foote receives Community Service Award

The World Parkinson’s Program annually recognizes three people for their work to improve the lives of people with Parkinson disease. This year, our neurosurgeon Dr. Kelly Foote received the Dr. Rana International Parkinson’s Community Service Award for the year 2015. This award honors Dr. Foote’s contributions to the field, his heart for patients, and his…

10 Parkinson’s Breakthroughs presented in Dr. Okun’s book

What are the potential treatment breakthroughs currently being explored for Parkinson’s disease? What are the details that patients need to know about those potential breakthroughs? That’s what Michael Okun, MD, Co-Director of our UF Health Center for Movement Disorders & Neurorestoration and Medical Director for National Parkinson Foundation works to answer in his latest book…

Nilotinib (Tasigna) for Parkinsons: Questions and Answers

Nilotinib (Tasigna) for Parkinsons: Questions and Answers. What is nilotinib (Tasigna)? Nilotinib is a FDA approved cancer drug for approved for use in certain types of chronic leukemia. Nilotinib is a protein kinase inhibitor that works by blocking abnormal protein signals which tell cancer cells to divide and multiply. The drug thus helps slow the…

“Psychogenic” speech disorders: is it all in your head?

What is a Psychogenic Speech Disorder?  A psychogenic speech disorder can be defined as a broad category of speech disturbances that represent the manifestation of one or more types of psychological processes. This can include, but is not limited to, anxiety, depression, conversion disorders, or an emotional response to a traumatic event. These psychological changes…

CurePSP Family Conceference Comes to Gainesville, FL

CurePSP is a foundation for PSP / CBD and related brain diseases. This year the CurePSP is holding its 2015 Southeastern Family Conference here in Gainesville, Florida on Saturday, February 7th from 9:00am – 4:15pm at the Best Western Gateway Grand Hotel near the Santa Fe College. The conference is geared toward patients, family and…